Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
NCT03391804
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Enteric Hyperoxaluria
Primary Hyperoxaluria
Hyperoxalemia
Interventions
DRUG:
ALLN-177
Sponsor
Allena Pharmaceuticals